Clinical Trial Update: Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial evaluating gabapentin for hot flashes in patients with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Hot Flashes, Prostate Cancer | Phase 3 | Status: COMPLETED